$ 0.7867 <%= Resources.Global.txtDown %>
Updated 21/05/2018
Change % -1.66% Stock price decreasing
Change -0.0133 Stock price decreasing
Volume 1,205,541
High $ 0.9049
Low $ 0.7511
Open $ 0.8292
Prev close $ 0.8000
# of shares 106.05M
Market cap 83.43M USD

Market closed
Vivus Inc
Market is closed, opens at 14:30
Price development Latest 1 week 1 month 3 months 6 months 1 year
  0.79 51.0% Stock price increasing 104.3% Stock price increasing 65.7% Stock price increasing 21.0% Stock price increasing -27.2% Stock price decreasing
Powered by TradingView

Company profile

VIVUS Inc is a US-based biopharmaceutical company which is engaged in developing and commercializing, next-generation therapies to address unmet medical needs in human health. The company's commercial products include Qsymia is an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index and Stendra/Spedra, which is an oral phosphodiesterase type 5 inhibitor for the treatment of erectile dysfunction. The company operates through the single segment of business being Development and commercialization of novel therapeutic products.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
22 May 2018 13:13:43
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180515.2 - EUROWEB2 - 2018-05-22 14:13:43 - 2018-05-22 13:13:43 - 1000 - Website: OKAY